David Roman, US medtech and healthcare IT research analyst for Goldman Sachs, said that AI play a 'significant' role in helping patients stay on top of their diabetes, with companies like Abbott and Dexcom using new technology to count carbohydrates and deliver the right amount of insulin. Roman, joined by Bloomberg health reporter Madison Muller, said that he came away from Goldman Sach's annual medtech conference 'very bullish' on innovation across the industry. (Source: Bloomberg)
David Roman, US medtech and healthcare IT research analyst for Goldman Sachs, said that AI play a 'significant' role in helping patients stay on top of their diabetes, with companies like Abbott and Dexcom using new technology to count carbohydrates and deliver the right amount of insulin. Roman, joined by Bloomberg health reporter Madison Muller, said that he came away from Goldman Sach's annual medtech conference 'very bullish' on innovation across the industry. (Source: Bloomberg)
Intuitive Surgical Inc. raised its fiscal 2026 outlook for use of its flagship surgical robotic system and reported first-quarter results that beat expectations, lifted by growing usage in the US and Europe.
Intuitive Surgical Inc. raised its fiscal 2026 outlook for use of its flagship surgical robotic system and reported first-quarter results that beat expectations, lifted by growing usage in the US and Europe.
A surgical robot, manufactured by Intuitive Surgical Inc., on display at the Viva Technology conference at Porte de Versailles exhibition center in Paris, France, on Wednesday, June 16, 2021. Viva Tech runs June 16 - 19.
Intuitive Surgical Inc. shares fell the most since October after it forecast slower growth for use of its flagship surgical robotic system system this year as rivals bring new products to market and procedure volumes are threatened by funding cuts to Medicaid and changes to Obamacare subsidies.
Intuitive Surgical Inc. shares fell the most since October after it forecast slower growth for use of its flagship surgical robotic system system this year as rivals bring new products to market and procedure volumes are threatened by funding cuts to Medicaid and changes to Obamacare subsidies.
An Intuitive Surgical surgical robot on display in Paris.
Intuitive Surgical Inc. shares fell the most since October after it forecast slower growth for use of its flagship surgical robotic system system this year as rivals bring new products to market and procedure volumes are threatened by funding cuts to Medicaid and changes to Obamacare subsidies.
Intuitive Surgical Inc. shares fell the most since October after it forecast slower growth for use of its flagship surgical robotic system system this year as rivals bring new products to market and procedure volumes are threatened by funding cuts to Medicaid and changes to Obamacare subsidies.
An Intuitive Surgical surgical robot on display in Paris.
Anmelden
